These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS. Davis JA; Horn DL; Marr KA; Fishman JA Transpl Infect Dis; 2009 Oct; 11(5):432-7. PubMed ID: 19638005 [TBL] [Abstract][Full Text] [Related]
4. Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co-infection. Okurut S; Boulware DR; Olobo J; Meya DB Mycoses; 2020 Aug; 63(8):840-853. PubMed ID: 32472727 [TBL] [Abstract][Full Text] [Related]
5. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease. Aaron PA; Vu K; Gelli A mBio; 2020 Jul; 11(4):. PubMed ID: 32694141 [No Abstract] [Full Text] [Related]
10. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. Chau TT; Mai NH; Phu NH; Nghia HD; Chuong LV; Sinh DX; Duong VA; Diep PT; Campbell JI; Baker S; Hien TT; Lalloo DG; Farrar JJ; Day JN BMC Infect Dis; 2010 Jul; 10():199. PubMed ID: 20618932 [TBL] [Abstract][Full Text] [Related]
11. Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis. Mohamed SH; Nyazika TK; Ssebambulidde K; Lionakis MS; Meya DB; Drummond RA Front Immunol; 2022; 13():804674. PubMed ID: 35432326 [TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Cryptococcal Meningitis: A Single United States Center Experience. Henao-MartÃnez AF; Gross L; Mcnair B; McCollister B; DeSanto K; Montoya JG; Shapiro L; Beckham JD Mycopathologia; 2016 Dec; 181(11-12):807-814. PubMed ID: 27502502 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and management of cryptococcal meningitis: developments and challenges. Pukkila-Worley R; Mylonakis E Expert Opin Pharmacother; 2008 Mar; 9(4):551-60. PubMed ID: 18312157 [TBL] [Abstract][Full Text] [Related]
14. Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier. Liu TB; Kim JC; Wang Y; Toffaletti DL; Eugenin E; Perfect JR; Kim KJ; Xue C PLoS Pathog; 2013; 9(4):e1003247. PubMed ID: 23592982 [TBL] [Abstract][Full Text] [Related]
15. The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Masso-Silva J; Espinosa V; Liu TB; Wang Y; Xue C; Rivera A mBio; 2018 Jan; 9(1):. PubMed ID: 29317510 [No Abstract] [Full Text] [Related]
16. Zebrafish Larvae as an Experimental Model of Cryptococcal Meningitis. Chalakova ZP; Johnston SA Methods Mol Biol; 2023; 2667():47-69. PubMed ID: 37145275 [TBL] [Abstract][Full Text] [Related]
17. Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease. Shourian M; Qureshi ST Front Immunol; 2019; 10():66. PubMed ID: 30761136 [No Abstract] [Full Text] [Related]
18. A Zebrafish Model of Cryptococcal Infection Reveals Roles for Macrophages, Endothelial Cells, and Neutrophils in the Establishment and Control of Sustained Fungemia. Davis JM; Huang M; Botts MR; Hull CM; Huttenlocher A Infect Immun; 2016 Oct; 84(10):3047-62. PubMed ID: 27481252 [TBL] [Abstract][Full Text] [Related]
19. Trojan Horse Transit Contributes to Blood-Brain Barrier Crossing of a Eukaryotic Pathogen. Santiago-Tirado FH; Onken MD; Cooper JA; Klein RS; Doering TL mBio; 2017 Jan; 8(1):. PubMed ID: 28143979 [TBL] [Abstract][Full Text] [Related]
20. The Rabbit Model of Cryptococcal Meningitis. Giamberardino C; Perfect JR Methods Mol Biol; 2024; 2775():13-27. PubMed ID: 38758308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]